ATROSIMAB Verified listing

Indicaton

inflammatory diseases (rheumatoid arthritis, Morbus Crohn), CNS diseases (Multiple Sclerosis, Alzheimer, Spinal Cord Injury), cardiovascular diseases (Myocardial infarction, TBI) and NASH

Therapeutic indications

Type of product

Antibody

Table

Phase

Phase I completed
Partnering status

Not partnered
Available in

Worldwide

You may also be interested in

Small molecule therapeutic that aims to treat Alzheimer’s patients

Alzheimer’s disease

Discovery

AUP-16 (AUP1602-C)

AUP-16 multi-targeting therapy for chronic wounds (Diabetic Foot Ulcers...) shows 50% improvement vs placebo in Phase-2 RCT

Phase II completed

Morphomer NLRP3-ASC

Neuroinflammation

Discovery

ATROSIMAB Verified listing

ATROSIMAB Verified listing

Indicaton

Therapeutic indications

Type of product

Company

Table

You may also be interested in

Small molecule therapeutic that aims to treat Alzheimer’s patients

AUP-16 (AUP1602-C)

Morphomer NLRP3-ASC